EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advancements in nanomedicines for cancer therapy: targeting molecular signaling pathways, activating immune cells, and using photothermal immunomodulation

Vishal Kumar Deb, Abhishek Mukherjee, Surajit Pathak, Sujay Paul, Asim K Duttaroy, Suman Adhikari

Frontiers in Bioengineering and Biotechnology · 10.04.2026 · 14

DOI: 10.3389/fbioe.2026.1775442 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 10.04.2026. Verfasst von Vishal Kumar Deb und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Health Sciences and Technology, UPES, Dehradun, Uttarakhand, India. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 169 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanoparticles are known for their unique physicochemical characteristics and large surface area. When these nanoparticles are functionalized with bioactive molecules or proteins, they enable highly efficient and targeted applications in cancer therapy. Early applications of nanotechnology in cancer treatment have centered on the properties of various nanomaterials, including organic, inorganic, and biological nanoparticles. For instance, stability, large-scale synthesis, and potential toxicity are crucial determinants of the use of nanotechnology in cancer treatment. For specific intervention, nanotechnology has focused on targeting dysregulated cancer signaling pathways. Concurrently, reprogramming tumor-associated macrophages, activating T and natural killer cells, and modulating cytokine profiles have become key components of nano-immunotherapy in combating tumor growth. Biomimetic nanotechnology, particularly nanoparticles wrapped in cancer cell membranes and photothermal immunotherapy based on two-dimensional (2D) nanomaterials, has shown potential as a new approach for cancer immunotherapy. Nevertheless, specific gaps in combination therapy, such as dose optimization and safety considerations, remain to be addressed in translational research. This review highlights mechanistic insights into nanoparticles that modulate cellular signaling pathways and activate immune cells, emphasizing 2D material-based nano-immune delivery systems as promising next-generation cancer treatments, with particular emphasis on photothermal therapy that could advance from preclinical to clinical settings.

Schlagwörter

Stichwörter der Autor:innen

cell signaling-targetclinical transitionimmune cell activationnanomedicinephotothermal therapytwo-domensional nanomedicine

Autor:innen und Institutionen

  • School of Health Sciences and Technology, UPES, Dehradun, Uttarakhand, India.
  • Ambinova Technologies Pvt Ltd., New Delhi, India.
  • Faculty of Allied Health Sciences, Chettinad Academy of Research and Education (CARE), Chettinad Hospital and Research Institute (CHRI), Chennai, India.
  • Tecnologico de Monterrey, School of Engineering and Sciences, Querétaro, Mexico.
  • Department of Nutrition, Institute of Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Department of Chemistry, Govt. Degree College, Dharmanagar, India.

Zitieren

APA

Deb, V. K., Mukherjee, A., Pathak, S., Paul, S., Duttaroy, A. K., & Adhikari, S. (2026). Advancements in nanomedicines for cancer therapy: targeting molecular signaling pathways, activating immune cells, and using photothermal immunomodulation. Frontiers in Bioengineering and Biotechnology, 14. https://doi.org/10.3389/fbioe.2026.1775442

Vancouver

Deb VK, Mukherjee A, Pathak S, Paul S, Duttaroy AK, Adhikari S. Advancements in nanomedicines for cancer therapy: targeting molecular signaling pathways, activating immune cells, and using photothermal immunomodulation. Frontiers in Bioengineering and Biotechnology. 2026;14. doi:10.3389/fbioe.2026.1775442

BibTeX
@article{Deb2026,
  author = {Deb, Vishal Kumar and Mukherjee, Abhishek and Pathak, Surajit and Paul, Sujay and Duttaroy, Asim K and Adhikari, Suman},
  title = {Advancements in nanomedicines for cancer therapy: targeting molecular signaling pathways, activating immune cells, and using photothermal immunomodulation},
  journal = {Frontiers in Bioengineering and Biotechnology},
  year = {2026},
  volume = {14},
  doi = {10.3389/fbioe.2026.1775442}
}
Kostenlos starten →